These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 15043881

  • 1. Virulence of Streptococcus pneumoniae may be determined independently of capsular polysaccharide.
    Mizrachi Nebenzahl Y, Porat N, Lifshitz S, Novick S, Levi A, Ling E, Liron O, Mordechai S, Sahu RK, Dagan R.
    FEMS Microbiol Lett; 2004 Apr 01; 233(1):147-52. PubMed ID: 15043881
    [Abstract] [Full Text] [Related]

  • 2. Ocular virulence of capsule-deficient streptococcus pneumoniae in a rabbit keratitis model.
    Reed JM, O'Callaghan RJ, Girgis DO, McCormick CC, Caballero AR, Marquart ME.
    Invest Ophthalmol Vis Sci; 2005 Feb 01; 46(2):604-8. PubMed ID: 15671288
    [Abstract] [Full Text] [Related]

  • 3. Virulence in mice of pneumococcal clonal types with known invasive disease potential in humans.
    Sandgren A, Albiger B, Orihuela CJ, Tuomanen E, Normark S, Henriques-Normark B.
    J Infect Dis; 2005 Sep 01; 192(5):791-800. PubMed ID: 16088828
    [Abstract] [Full Text] [Related]

  • 4. Polyvalent 23 epitope polysaccharide pneumonia vaccine induced effective protection through strain-adapted effector mechanisms as demonstrated by the different cytokine responses in mice challenged with two different strains of Streptococcus pneumoniae.
    Mohler J, Moine P, Azoulay-Dupuis E, Henin D, Fantin B.
    Eur Cytokine Netw; 2007 Mar 01; 18(1):23-30. PubMed ID: 17400535
    [Abstract] [Full Text] [Related]

  • 5. Drastic reduction in the virulence of Streptococcus pneumoniae expressing type 2 capsular polysaccharide but lacking choline residues in the cell wall.
    Kharat AS, Tomasz A.
    Mol Microbiol; 2006 Apr 01; 60(1):93-107. PubMed ID: 16556223
    [Abstract] [Full Text] [Related]

  • 6. The effect that mutations in the conserved capsular polysaccharide biosynthesis genes cpsA, cpsB, and cpsD have on virulence of Streptococcus pneumoniae.
    Morona JK, Miller DC, Morona R, Paton JC.
    J Infect Dis; 2004 May 15; 189(10):1905-13. PubMed ID: 15122528
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Specific antibodies, levofloxacin, and modulation of capsule-associated virulence in Streptococcus pneumoniae.
    Tarragó D, Lara N, Fenoll A, Casal J, Giménez MJ, Aguilar L, Sevillano D.
    Antimicrob Agents Chemother; 2005 Jul 15; 49(7):3095-6. PubMed ID: 15980409
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Development of 5-valent conjugate pneumococcal protein A - Capsular polysaccharide pneumococcal vaccine against invasive pneumococcal disease.
    Meng C, Lin H, Huang J, Wang H, Cai Q, Fang L, Guo Y.
    Microb Pathog; 2009 Sep 15; 47(3):151-6. PubMed ID: 19467319
    [Abstract] [Full Text] [Related]

  • 12. Requirement for capsule in colonization by Streptococcus pneumoniae.
    Magee AD, Yother J.
    Infect Immun; 2001 Jun 15; 69(6):3755-61. PubMed ID: 11349040
    [Abstract] [Full Text] [Related]

  • 13. The capsule of Streptococcus pneumoniae contributes to virulence in the insect model Manduca sexta.
    Roth A, Reichmann P, Hakenbeck R.
    J Mol Microbiol Biotechnol; 2012 Jun 15; 22(5):326-34. PubMed ID: 23221622
    [Abstract] [Full Text] [Related]

  • 14. Peptide mimics of two pneumococcal capsular polysaccharide serotypes (6B and 9V) protect mice from a lethal challenge with Streptococcus pneumoniae.
    Smith CM, Lo Passo C, Scuderi A, Kolberg J, Baxendale H, Goldblatt D, Oggioni MR, Felici F, Andrew PW.
    Eur J Immunol; 2009 Jun 15; 39(6):1527-35. PubMed ID: 19499518
    [Abstract] [Full Text] [Related]

  • 15. What is different about serotype 1 pneumococci?
    Ritchie ND, Mitchell TJ, Evans TJ.
    Future Microbiol; 2012 Jan 15; 7(1):33-46. PubMed ID: 22191445
    [Abstract] [Full Text] [Related]

  • 16. Tissue-specific contributions of pneumococcal virulence factors to pathogenesis.
    Orihuela CJ, Gao G, Francis KP, Yu J, Tuomanen EI.
    J Infect Dis; 2004 Nov 01; 190(9):1661-9. PubMed ID: 15478073
    [Abstract] [Full Text] [Related]

  • 17. Enhanced vulnerability for Streptococcus pneumoniae sepsis during asplenia is determined by the bacterial capsule.
    Lammers AJ, de Porto AP, Florquin S, de Boer OJ, Bootsma HJ, Hermans PW, van der Poll T.
    Immunobiology; 2011 Aug 01; 216(8):863-70. PubMed ID: 21397979
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Comparison of the pulmonary response against lethal and non-lethal intranasal challenges with two different pneumococcal strains.
    Ferreira DM, Moreno AT, Cianciarullo AM, Ho PL, Oliveira ML, Miyaji EN.
    Microb Pathog; 2009 Sep 01; 47(3):157-63. PubMed ID: 19467320
    [Abstract] [Full Text] [Related]

  • 20. Nitric oxide exerts distinct effects in local and systemic infections with Streptococcus pneumoniae.
    Kerr AR, Wei XQ, Andrew PW, Mitchell TJ.
    Microb Pathog; 2004 Jun 01; 36(6):303-10. PubMed ID: 15120156
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.